Skyrocketing Prescription Drug Prices
DOWNLOAD
Download Skyrocketing Prescription Drug Prices PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Skyrocketing Prescription Drug Prices book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Skyrocketing Prescription Drug Prices
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Drugs categories.
Skyrocketing Prescription Drug Prices
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Drugs categories.
Skyrocketing Prescription Drug Prices Hearings Before The Senate Special Committee On Aging
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices Hearings Before The Senate Special Committee On Aging written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with categories.
Skyrocketing Prescription Drug Prices
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Drugs categories.
Skyrocketing Prescription Drug Costs
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1992
Skyrocketing Prescription Drug Costs written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1992 with Business & Economics categories.
Skyrocketing Prescription Drug Prices
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Drugs categories.
Skyrocketing Prescription Drug Prices
DOWNLOAD
Author : United States. Congress. Senate. Special Committee on Aging
language : en
Publisher:
Release Date : 1990
Skyrocketing Prescription Drug Prices written by United States. Congress. Senate. Special Committee on Aging and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 1990 with Drugs categories.
The Right Price
DOWNLOAD
Author : Peter J. Neumann
language : en
Publisher: Oxford University Press
Release Date : 2021-05-06
The Right Price written by Peter J. Neumann and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021-05-06 with Medical categories.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only intensify. The Right Price sheds light on the controversial topic of drug pricing by providing an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It illustrates the need for value-based pricing through real-life stories of patients and their experiences with the drug industry and explains why simple solutions like price controls and the importation of cheaper drugs from other countries are problematic. This volume describes how researchers and policy makers have pursued drug valuation efforts in the past, and lays out a series of recommendations, based on years of shared author experience serving on national drug policy platforms, for how to further improve pharmaceutical value assessment in the United States. With unique industry insights and clear narrative, The Right Price unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
Prescription Drug Pricing Background Discount Programs And Cost Lowering Strategies
DOWNLOAD
Author : Elias B. Toft
language : en
Publisher: Nova Snova
Release Date : 2020-03-13
Prescription Drug Pricing Background Discount Programs And Cost Lowering Strategies written by Elias B. Toft and has been published by Nova Snova this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-03-13 with categories.
Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.
Making Medicines Affordable
DOWNLOAD
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01
Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.